InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Agarwal Shefali. Director active across 2 companies, notably Fate Therapeutics INC. Cumulatively, 14 reports have been logged. Split: 0 buy · 7 sells. Total volume traded: €49k. Activity tracked since 2 June 2021. The latest transaction was disclosed on 9 August 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Agarwal Shefali
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
179,247 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028867:0
107,292 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028867:1
56,527 shares@ US$1.3971.0% of flowCommon Stock, par value $0.0001SEC:0000899243-22-028419:0
8,650 shares0Common StockSEC:0001209191-22-036338:0
841 shares@ US$21.890.0084% mcap50.1% of flowCommon StockSEC:0001209191-22-034996:0
00Common StockSEC:0001209191-22-034992:0
807 shares@ US$22.800.0084% mcap49.9% of flowCommon StockSEC:0001209191-22-034536:0
2,331 shares@ US$1.26652.8% of flowCommon StockSEC:0000899243-22-011725:0
1,058 shares@ US$1.501.5% of flowCommon Stock, par value $0.0001SEC:0000899243-22-005470:0
2,639 shares@ US$1.373.4% of flowCommon Stock, par value $0.0001SEC:0000899243-22-004829:0
2,922 shares@ US$2.025.6% of flowCommon Stock, par value $0.0001SEC:0000899243-22-003557:0
1,780 shares@ US$2.934.9% of flowCommon Stock, par value $0.0001SEC:0000899243-21-047205:0
59,166 shares0Common Stock, par value $0.0001SEC:0000899243-21-033398:0
2,681 shares0Common StockSEC:0000899243-21-022080:0
14 of 14 declarations
About Agarwal Shefali
Agarwal Shefali is a declarant associated with Epizyme, Inc. and Fate Therapeutics INC, where the listed role is Director. She has 14 filings in total, and across the sampled recent filings from 2021-06-04 to 2022-08-16, the sell amount is EUR 48749, with modal transaction nature Cession.
